Navigation Links
AACR to host second Frontiers in Basic Cancer Research Conference
Date:9/12/2011

SAN FRANCISCO The American Association for Cancer Research will host its Second AACR International Conference on Frontiers in Basic Cancer Research at the InterContinental San Francisco Hotel from Sept. 14-18, 2011.

This conference is an opportunity for the world's leading scientists to share ideas and breakthroughs that will expedite the development of lifesaving cancer therapeutics from the lab to the clinic.

"We are truly in an exciting period for cancer research, as work that started by addressing basic questions about cancer is coming to clinical fruition. The more we can collaborate and reach synergy through conferences like this, the closer we will come to lifesaving treatments," said conference chairperson Elizabeth H. Blackburn, Ph.D., the Morris Herzstein professor of biology and physiology in the department of biochemistry and biophysics at the University of California, San Francisco.

Blackburn, immediate past president of the AACR, won the 2009 Nobel Prize in Physiology or Medicine for her role in the discovery of telomerase.

On Thursday, Sept. 15, 2011, at 10:00 a.m. PT, conference co-chairperson Ren Bernards, Ph.D., professor of molecular carcinogenesis at The Netherlands Cancer Institute in Amsterdam, will host a press conference on the following research.

The following information is embargoed until 10:00 a.m. PT on Thursday, Sept. 15.

  • Inner Workings of Virus Responsible for Rare Skin Cancer
  • EGFR Essential for the Development of Pancreatic Cancer
  • Finding Pathways to Cancer Progression may Lead to Identification of Targeted Therapies
  • Virus Shows Promise for Imaging and Treating Pancreatic Cancer

Reporters who cannot attend in person can participate by using the following information:

  • U.S. and Canada: (888) 647-7462
  • International: (201) 604-0169


'/>"/>

Contact: Jeremy Moore
Jeremy.Moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. Aware, Inc. Reports Second Quarter 2011 Financial Results
2. Aware, Inc. Reports Second Quarter 2011 Financial Results
3. 2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma
4. PSA test for men could get a second life for breast cancer in women
5. NJIT receives second part of $1M gift to chemical engineering department
6. Malaria against malaria: A pre-existing malaria infection can prevent a second infection
7. Frequent CT scanning for testicular cancer surveillance associated with secondary malignancies
8. Banana peels get a second life as water purifier
9. International experts to converge in Singapore for second Keystone Symposia Conference on Biofuels
10. A second pathway for antidepressants
11. Out of mind in a matter of seconds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... the launch of the Supplyframe Design Lab . Located in Pasadena, Calif., ... the future of how hardware projects are designed, built and brought to market. ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
Breaking Biology Technology: